Long Non-coding RNA Expression in Bladder Cancer

Overview

Journal Biophys Rev

Publisher Springer

Specialty Biophysics

Date 2017 Dec 10

PMID 29222807

Citations 41

Authors

Mohammad Taheri

Mir Davood Omrani

Soudeh Ghafouri-Fard

Affiliations

Soon will be listed here.

Abstract

The advent of novel high-throughput sequencing methods has facilitated identification of non-coding RNAs with fundamental roles in cellular biological and pathological conditions. A group of these consisting of at least 200 nucleotides are called long non-coding RNAs (lncRNAs). Their participation in the pathogenesis of cancer has been highlighted in recent years. Bladder cancer, one of the most prevalent cancers worldwide, exhibits altered expression levels of several lncRNAs. Several in vitro and in vivo studies have assessed the effects of silencing RNAs on cancer cell phenotypes and in vivo tumor growth. For instance, in vitro studies have shown that nuclear paraspeckle assembly transcript 1 (NEAT1), promoter of CDKN1A antisense DNA damage-activated RNA(PANDAR) and metastasis-associated lung adenocarcinoma transcript 1(MALAT1) have oncogenic effects while Maternally expressed 3 (MEG3) and BRAF activated non-coding RNA (BANCR) are tumor suppressors. Analysis of these data will help to identify a panel of lncRNAs that can be potentially used for both early detection and prognosis in bladder cancer patients. Here, we review the roles of several lncRNAs in the oncogenesis, tumor suppression, early detection, and prognosis of bladder cancer.

Citing Articles

Long non-coding RNAs: regulators of autophagy and potential biomarkers in therapy resistance and urological cancers.

Wang S, Bai Y, Ma J, Qiao L, Zhang M Front Pharmacol. 2024; 15:1442227.

PMID: 39512820 PMC: 11540796. DOI: 10.3389/fphar.2024.1442227.

Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.

Zhou W, Yang Y, Wang W, Yang C, Cao Z, Lin X Cell Cycle. 2024; 23(6):645-661.

PMID: 38842275 PMC: 11229759. DOI: 10.1080/15384101.2024.2353554.

Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism.

Hashem M, Khosroshahi E, Aliahmady M, Ghanei M, Rezaie Y, Jafari Y Noncoding RNA Res. 2024; 9(2):560-582.

PMID: 38515791 PMC: 10955558. DOI: 10.1016/j.ncrna.2024.01.009.

m6A Methylation-Mediated Stabilization of LINC01106 Suppresses Bladder Cancer Progression by Regulating the miR-3148/DAB1 Axis.

Liu J, Tian C, Qiao J, Deng K, Ye X, Xiong L Biomedicines. 2024; 12(1).

PMID: 38255219 PMC: 10813768. DOI: 10.3390/biomedicines12010114.

LncRNA OIP5-AS1 Targets the miR-140-5p/UBR5 Cascade to Promote the Development of Gastric Cancer.

Liu M, Song X, Sun Y, Zhang T Mol Biotechnol. 2023; 66(12):3583-3596.

PMID: 38112962 DOI: 10.1007/s12033-023-00958-x.

References

Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia M . Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Cancer Lett. 2016; 376(1):155-64. DOI: 10.1016/j.canlet.2016.03.037. View

Sun L, Xue H, Jiang C, Zhou H, Gu L, Liu Y . LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo. Biosci Rep. 2016; 36(3). PMC: 4859087. DOI: 10.1042/BSR20160048. View

Ghafouri-Fard S, Nekoohesh L, Motevaseli E . Bladder cancer biomarkers: review and update. Asian Pac J Cancer Prev. 2014; 15(6):2395-403. DOI: 10.7314/apjcp.2014.15.6.2395. View

Li C, Cui Y, Liu L, Ren W, Li Q, Zhou X . High Expression of Long Noncoding RNA MALAT1 Indicates a Poor Prognosis and Promotes Clinical Progression and Metastasis in Bladder Cancer. Clin Genitourin Cancer. 2017; 15(5):570-576. DOI: 10.1016/j.clgc.2017.05.001. View

Taheri M, Habibi M, Noroozi R, Rakhshan A, Sarrafzadeh S, Sayad A . HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population. Gene. 2017; 613:20-24. DOI: 10.1016/j.gene.2017.02.031. View

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J . Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Cancer Lett. 2013; 333(2):213-21. DOI: 10.1016/j.canlet.2013.01.033. View

Sarrafzadeh S, Geranpayeh L, Tasharrofi B, Soudyab M, Nikpayam E, Iranpour M . Expression Study and Clinical Correlations of MYC and CCAT2 in Breast Cancer Patients. Iran Biomed J. 2017; 21(5):303-11. PMC: 5548962. DOI: 10.18869/acadpub.ibj.21.5.303. View

Tan J, Qiu K, Li M, Liang Y . Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett. 2015; 589(20 Pt B):3175-81. DOI: 10.1016/j.febslet.2015.08.020. View

Wang Y, Wu Z, Wang G, Liu K, Niu X, Gu S . LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p. Tumour Biol. 2016; 37(11):14553-14563. DOI: 10.1007/s13277-016-5303-8. View

10.

Dianatpour A, Ghafouri-Fard S . The Role of Long Non Coding RNAs in the Repair of DNA Double Strand Breaks. Int J Mol Cell Med. 2017; 6(1):1-12. PMC: 5568187. View

11.

Zhan Y, Liu Y, Wang C, Lin J, Chen M, Chen X . Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Oncotarget. 2016; 7(13):16038-48. PMC: 4941296. DOI: 10.18632/oncotarget.6946. View

12.

Li L, Zhu J, Bao W, Chen D, Huang W, Weng Z . Long noncoding RNA GHET1 promotes the development of bladder cancer. Int J Clin Exp Pathol. 2014; 7(10):7196-205. PMC: 4230137. View

13.

Greife A, Knievel J, Ribarska T, Niegisch G, Schulz W . Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma. Clin Epigenetics. 2015; 6(1):29. PMC: 4348104. DOI: 10.1186/1868-7083-6-29. View

14.

Nikpayam E, Tasharrofi B, Sarrafzadeh S, Ghafouri-Fard S . The Role of Long Non-Coding RNAs in Ovarian Cancer. Iran Biomed J. 2016; 21(1):3-15. PMC: 5141251. DOI: 10.6091/.21.1.24. View

15.

Qi P, Xu M, Ni S, Shen X, Wei P, Huang D . Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients. Mol Carcinog. 2014; 54(9):742-50. DOI: 10.1002/mc.22137. View

16.

Peter S, Borkowska E, Drayton R, Rakhit C, Noon A, Chen W . Identification of differentially expressed long noncoding RNAs in bladder cancer. Clin Cancer Res. 2014; 20(20):5311-21. DOI: 10.1158/1078-0432.CCR-14-0706. View

17.

Kretz M, Siprashvili Z, Chu C, Webster D, Zehnder A, Qu K . Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature. 2012; 493(7431):231-5. PMC: 3674581. DOI: 10.1038/nature11661. View

18.

Duan W, Du L, Jiang X, Wang R, Yan S, Xie Y . Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget. 2016; 7(48):78850-78858. PMC: 5346682. DOI: 10.18632/oncotarget.12880. View

19.

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J . Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013; 280(7):1709-16. DOI: 10.1111/febs.12185. View

20.

Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F . Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol Biosyst. 2012; 8(9):2289-94. DOI: 10.1039/c2mb25070e. View